During the @-month treatment period , the primary outcome occurred in @ of @ patients ( @ % ) in the warfarin group and in @ of @ ( @ % ) in the placebo group ( hazard ratio -LSB- HR -RSB- , @ ; @ % CI , @-@ @ ; P = @ ) .